Modulation of the Gut Microbiome by Novel Synthetic Glycans for the Production of Propionate and the Reduction of Cardiometabolic Risk Factors

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Increasing evidence indicates that an altered gut microbiome participates in the development of cardiometabolic syndrome and associated risk factors, such as insulin resistance, dyslipidemia, and obesity, and that targeting the gut microbiome is a promising strategy to lower the risk for cardiometabolic diseases. Part of this reduction is mediated by specific metabolites gen...

Topics

Open a Topic to create a Post that cites this publication.

• Advanced Glycation End Products research
• Clostridium difficile and Clostridium perfringens research
• Diet and metabolism studies
• Dietary Effects on Health
• Gastrointestinal motility and disorders
• Gut microbiota and health
• Metabolomics and Mass Spectrometry Studies
• Probiotics and Fermented Foods

Identifiers and source

Literature Corpus work

2d44b2a5-2ed2-53d0-9acf-e725d3036ca9

DOI

10.1101/2022.04.04.487010